Literature DB >> 9850867

T-cell survival.

P Marrack1, T Mitchell, J Bender, D Hildeman, R Kedl, K Teague, J Kappler.   

Abstract

Like other cells, T cells are dependent on signals from their environment for their survival. Resting T cells are supported in vitro by cytokines such as interleukin (IL)-4, IL-6 and IL-7. The latter two cytokines are made constitutively in animals and hence might affect the lifetimes of their resting T cells. Resting T cells are also kept alive by interaction with an as yet unidentified molecule on the surface of other cells. Activated T cells are also supported in vitro by members of two families of these proteins, the IL-2 family and the interferon-alpha beta family. Members of the latter family may have effects on activated cells in vivo. Thus although both resting and activated T cells require signals to keep themselves alive, the signals are different for the two types of cells. This perhaps allows the immune response to control the numbers of activated cells during infections without compromising its pool of precursor, resting T cells.

Entities:  

Mesh:

Year:  1998        PMID: 9850867     DOI: 10.1111/j.1600-065x.1998.tb01245.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

1.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Dendritic cells control T cell tonic signaling required for responsiveness to foreign antigen.

Authors:  Kristin Hochweller; Guido H Wabnitz; Yvonne Samstag; Janine Suffner; Günter J Hämmerling; Natalio Garbi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

4.  The protooncogene MYC can break B cell tolerance.

Authors:  Yosef Refaeli; Kenneth A Field; Brian C Turner; Andreas Trumpp; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

5.  BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection.

Authors:  Silke F Fischer; Gabrielle T Belz; Andreas Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

6.  Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.

Authors:  G A D Hardy; N Imami; A K Sullivan; A Pires; C T Burton; M R Nelson; B G Gazzard; F M Gotch
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Dynamical modelling of haematopoiesis: an integrated view over the system in homeostasis and under perturbation.

Authors:  Erica Manesso; José Teles; David Bryder; Carsten Peterson
Journal:  J R Soc Interface       Date:  2013-03-06       Impact factor: 4.118

8.  Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.

Authors:  E O'Flaherty; W K Wong; S J Pettit; K Seymour; S Ali; J A Kirby
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

9.  FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.

Authors:  Stephanie K Watkins; Ziqiang Zhu; Elena Riboldi; Kim A Shafer-Weaver; Katherine E R Stagliano; Martha M Sklavos; Stefan Ambs; Hideo Yagita; Arthur A Hurwitz
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

10.  Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.

Authors:  Peter N Lalli; Michael G Strainic; Min Yang; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.